BREAST MILK FILTRATION DEVICE AND METHOD
20230233744 · 2023-07-27
Inventors
Cpc classification
A61K31/53
HUMAN NECESSITIES
International classification
Abstract
A system and method configured to separate PFAS from expressed breast milk, thereby producing breast milk which is essentially free (or at least contains a lesser amount of) per- and polyfluorinated substances, the system and method including filtration device including an adapter configured to be at least one of positioned in-line in a breast pump or between breast milk containers, and including a replaceable cyclodextrin based filter for filtration of PFAS from pumped breast milk.
Claims
1. A filtration assembly configured to filter PFAS from breast milk, comprising: a filtration device configured to be positioned between a first collection unit and a second collection unit, wherein the filtration device is coupled to at least one of the first collection unit or the second collection unit and either including a quantity of breast milk; the quantity of breast milk possibly containing a quantity of PFAS, wherein the filtration device is integrated with a filter, selectively positioned within the filtration device, to reduce the quantity of PFAS contained within the breast milk, wherein the quantity of breast milk is transferred from one collection unit to another; and the quantity of breast milk processes through the filter and reduces the quantity of PFAS contained within the breast milk.
2. The filtration assembly of claim 1, wherein the first collection unit is a breast pump, such that the filtration device is positioned in-line with the breast pump to deliver the quantity of breast milk through the filter while the breast pump is in operation; and the second collection unit to receive the quantity of breast milk.
3. The filtration assembly of claim 1, wherein the first collection unit is a first bottle and the second collection unit is a second bottle, such that the quantity of breast milk is transferred from one bottle to the other and passes through the filter.
4. The filtration assembly of claim 1, wherein the filtration device can define a first threading at a first end and a second threading at a second end, opposite the first end, configured to threadably couple a threaded portion of the first collection unit and the second collection unit, respectively, to form a liquid seal.
5. The filtration assembly of claim 1, wherein the filtration device relies on at least one of gravity or pressurization within the filtration device to process the quantity of breast milk through the filter.
6. The filtration assembly of claim 1, wherein the filter includes cyclodextrin.
7. The filtration assembly of claim 6, wherein the filter reduces the quantity of PFAS from the breast milk without significantly changing the nutritional profile of the breast milk.
8. The filtration assembly of claim 7, wherein the without significantly changing the nutritional profile of breast milk includes reducing the quantity of PFAS concentration by 5% or less.
9. The filtration assembly of claim 1, wherein a valve is integrated into the filtration device and is configured to release gas trapped within the first collection unit, second collection unit or the filtration device.
10. The filtration assembly of claim 1, wherein the filter is integrated with a brace configured to retain the filter in position relative to the filtration device during use.
11. The filtration assembly of claim 1, wherein the filter is a composed, compact disc and readily inserted and removed from the filtration device.
12. A method of filtering PFAS from breast milk, comprising: positioning a filtration device between a first collection unit and a second collection unit, wherein the filtration device is coupled to at least one of the first collection unit or the second collection unit and either including a quantity of breast milk; transferring the quantity of breast milk from one collection unit to another, the quantity of breast milk passing through a filter selectively positioned within the filtration device, wherein the filter reduces a quantity of PFAS possibly contained in the quantity of breast milk; and reducing the quantity of PFAS from the quantity of breast milk.
13. The method of claim 12, further comprising positioning the filtration device in-line with a breast pump, the breast pump being the first collection unit; delivering the quantity of breast milk from the breast pump through the filter; and receiving the quantity of breast milk by a collection bottle, the collection bottle being the second collection unit.
14. The method of claim 12, further comprising threadably coupling the filtration device at a first end with the first collection unit; and threadably coupling the filtration device at a second end, opposite the first end, with the second collection unit, wherein the threadable connections form a liquid seal.
15. The method of claim 12, further comprising including cyclodextrin within the filter.
16. The method of claim 15, further comprising reducing the quantity of PFAS from the breast milk without significantly altering the nutritional profile of the breast milk.
17. The method of claim 16, further comprising only reducing the quantity of PFAS from the breast milk by 5% or less.
18. The method of claim 12, further comprising integrating a valve with the filtration device for automatic releasing of gas trapped within the first collection unit, the second collection unit or the filtration device.
19. The method of claim 12, further comprising integrating a brace with the filter for retaining the filter in position relative to the filtration device during use.
20. The method of claim 12, further comprising constructing the filter as a composed, compact disc for readable insertion and removal from the filtration device.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0010] The disclosure can be more completely understood in consideration of the following detailed description of various embodiments of the disclosure, in connection with the accompanying drawings, in which:
[0011]
[0012]
[0013]
[0014]
[0015]
[0016]
[0017]
[0018] While embodiments of the disclosure are amenable to various modifications and alternative forms, specifics thereof shown by way of example in the drawings will be described in detail. It should be understood, however, that the intention is not to limit the disclosure to the particular embodiments described. On the contrary, the intention is to cover all modifications, equivalents, and alternatives falling within the spirit and scope of the subject matter as defined by the claims.
DETAILED DESCRIPTION
[0019] Reference now will be made in detail to embodiments of the disclosure, one or more examples of which are illustrated in the drawings. Each example is provided by way of explanation in the disclosure and is not limited thereto. In fact, it will be apparent to those skilled in the art that various modifications and variations can be made in the present disclosure without departing from the scope of the disclosure. For instance, features illustrated or described as part of one embodiment can be used with another embodiment to yield a still further embodiment. Thus, it is intended that the present disclosure covers such modifications and variations as come within the scope of the appended claims and their equivalents. As used herein, the term “or” is generally intended to be inclusive (i.e., “A or B” is intended to mean “A or B or both”). The terms “first,” “second,” and “third” may be used interchangeably to distinguish one component from another and are not intended to signify location or importance of the individual components.
[0020] Throughout the specification, and in the claims, the term “connected” means a direct electrical, mechanical, or magnetic connection between the things that are connected, without any intermediary devices. The terms “coupled” or “integrated” mean either a direct electrical, mechanical, or magnetic connection between the things that are connected or an indirect connection through one or more passive or active intermediary devices. The term “circuit,” “module,” or “mechanism” may refer to one or more passive and/or active components that are arranged to cooperate with one another to provide a desired function.
[0021] The terms “substantially,” “close,” “approximately,” “near,” and “about” generally refer to being within +/−10% of a target value. Unless otherwise specified the use of the ordinal adjectives “first,” “second,” and “third,” etc., to describe a common object, merely indicate that different instances of like objects are being referred to and are not intended to imply that the objects so described must be in a given sequence, either temporally, spatially, in ranking, or in any other manner. It is to be understood that the terms so used are interchangeable under appropriate circumstances such that the embodiments of the disclosure described herein are, for example, capable of operation in other orientations than those illustrated or otherwise described herein.
[0022] The terms “left,” “right,” “front,” “back,” “top,” “bottom,” “over,” “under,” and the like in the description and in the claims, if any, are used for descriptive purposes and not necessarily for describing permanent relative positions.
[0023] As described herein, embodiment of the present disclosure provides systems and methods related to instruments or tools used to perform surgery on a patient and, more particularly, to surgical instruments with enhanced ultrasonic tissue dissection.
[0024] Breast pumps for use by nursing mothers are well known. They allow the nursing woman to express the breast milk as necessary or convenient, and further provide collection of the breast milk for later use. There are three general broad classifications of breast pumps: (1) hand pumps that generate suction manually, (2) battery operated pumps with small motors that generate suction from power supplied by batteries, and (3) electric pumps in which suction is created by various types of electric motors that run off a 120V alternating current supply. Some pumps can cross over these broad classifications. Various example breast pumps are disclosed in U.S. Pat. No. 8,070,715, the contents of which are incorporated by reference herein to the extent that they do not conflict with the contents of this disclosure.
[0025] Embodiments of the present disclosure provide a system and method configured to filter or otherwise separate PFAS from expressed breast milk. In particular, with reference to
[0026] In embodiments, a first collection bottle 102 may contain an amount of unfiltered breast milk, wherein the first collection bottle 102 may be coupled to the filtration device 100. In embodiments, the filtration device 100 and first collection bottle 102 may be threadably coupled together by the first existing threading 104 and the first internal threading 106, forming a liquid seal. In embodiments, where there may not be threading (e.g., on either the first collection bottle 102 or the filtration device 100), the filtration device 100 may receive (e.g., slide onto) the first collection bottle 102, forming a liquid seal. In embodiments, the filtration device 100 and second collection bottle 112 may be threadably coupled together by the second existing threading 114 and the second internal threading 116, forming a liquid seal. In embodiments, where there may not be threading (e.g., on either the second collection bottle 112 or the filtration device 100), the filtration device 100 may receive the second collection bottle 112, forming a liquid seal.
[0027] In embodiments, once at least the first collection bottle 102 is in fluid communication with the filter device 100 (and the second collection bottle 112, if attached), the first collection bottle 102 may be tilted or inverted. Thus, the liquid within the first collection bottle 102 (e.g., the unfiltered breast milk) may flow from the first collection bottle 102, through the filter 120, and, thus, through the filtration device 100. In embodiments, the filtration device 100 may rely on gravity to process the unfiltered breast milk through filter 120. In other embodiments, the breast milk can be pressurized as an aid in causing the breast milk to flow through the filtration device 100. Other embodiments are also contemplated. In embodiments, the filtration device 100, particularly the filter 120, may filter out PFAS and other micropollutants that may be retained in the unfiltered breast milk or other liquid. In embodiments, the second collection bottle 116 may also be fluidly coupled to the filtration device 100 to receive the now filtered or becoming filtered breast milk, in real time, from the first collection bottle 102. In embodiments, not only are the PFAS and other micropollutants removed, the filtration device 100 may filter the breast milk without altering (or minimally altering) the nutritional profile of the breast milk. In embodiments, the filtration device 100 can reduce PFAS concentration in breast milk by up to 85%. In embodiments, the filtration device 100 can reduce PFAS concentration in breast milk by up to 90%. In embodiments, the filtration device 100 can reduce PFAS concentration in breast milk by greater than or equal to 90%. In embodiments, the filtration device 100 can reduce PFAS concentration in breast milk by greater than 99%. In embodiments, the reduction or removal of PFAS concentration may be performed while minimally altering the milks nutritional profile by 5% or less.
[0028] With additional reference to
[0029] In some embodiments, the filter 120 and corresponding filters as illustrated herein can generally include cyclodextrin 121. Cyclodextrins are a family of cyclic oligosaccharides, consisting of a macrocyclic ring of glucose subunits joined by α-1,4 glycosidic bonds. Cyclodextrins are produced from starch by enzymatic conversion. Cyclodextrins are composed of 5 or more α-D-glucopyranoside units linked 1->4, as in amylose (a fragment of starch). The largest cyclodextrin contains 32 1,4-anhydroglucopyranoside units, while as a poorly characterized mixture, at least 150-membered cyclic oligosaccharides are also known. Typical cyclodextrins contain a number of glucose monomers ranging from six to eight units in a ring. With a hydrophobic interior and hydrophilic exterior, cyclodextrins form complexes with hydrophobic compounds. Alpha-, beta-, and gamma-cyclodextrin are all generally recognized as safe by the U.S. FDA. In some embodiments, the cyclodextrin can be a powder form contained between two layers of retaining tissue or fabric. In some embodiments, the filter can generally be in the form of a patch, which can be selectively positioned within the filtration device 100. In embodiments, the filter 120 can generally be in the form of a disc like shape, which can be selectively positioned within the filtration device 100. In embodiments, the filter 120 can be incorporated with cyclodextrin in a compact or composed, single unit such that the filter 120 may be interchangeable and readily removed for cleaning or replaced.
[0030] Referring to
[0031] Referring to
[0032]
[0033] In embodiments, the connector 202 may distribute, from a breast pump, an amount of unfiltered breast milk, wherein the connector 202 may be coupled to the filtration device 200. In embodiments, the filtration device 200 and connector 202 may be threadably coupled together between the threading on the connector (not shown) and the first internal threading 206, forming a liquid seal. In embodiments, where there may not be threading (e.g., on either the connector 202 or the filtration device 200, the filtration device 200 may receive (e.g., slide onto) the connector 202, forming a liquid seal. In embodiments, the filtration device 200 and collection bottle 212 may be threadably coupled together between the second existing threading 214 and the second internal threading 216, forming a liquid seal. In embodiments, where there may not be threading (e.g., on either the collection bottle 212 or the filtration device 200, the filtration device 200 may receive the collection bottle 212, forming a liquid seal.
[0034] In embodiments, once at least the connector 202 is in fluid communication with the filtration device 200 (and the collection bottle 212, if attached) and the breast pump, the breast pump may be activated. In embodiments, the filtration device 200 may filter the unfiltered breast milk, in real-time (i.e., continuously, during extraction of breast milk from the breast pump). In embodiments, the filtration device 200, particularly the filter 220 (further depicted in
[0035] In some embodiments, the filtration device 200 can include a valve 232 configured to enable gas that may be trapped within the collection bottle 212 or filtration device 200 to escape as breast milk flows into the collection bottle 212 and displaces the gas. In embodiments, the filtration device 200 may filter the breast milk during operation of the breast pump without impeding pump-flow rate and without impeding (or minimally impeding) comfort to the user.
[0036] With additional reference to
[0037]
[0038] In embodiments, a first collection bottle 302 may contain an amount of unfiltered breast milk, wherein the first collection bottle 302 may be coupled to the filtration device 300, via an extension 308, similarly depicted in
[0039] In embodiments, once at least the first collection bottle 302 is in fluid communication with the filtration device 300, via the extension 308, (and the second collection bottle 312, if attached), the first filtration device 302 may be tilted or inverted. Thus, the breast liquid within the first collection bottle 302 (e.g., the unfiltered breast milk) may flow from the first collection bottle 302, through extension 308, potentially building up within, and through the filter 300. In embodiments, the filtration device 300 may rely on gravity to process the unfiltered breast milk through filter 320. In other embodiments, the breast milk can be pressurized as an aid in causing the breast milk to flow through the filtration device 300. Other embodiments are also contemplated. In embodiments, the filtration device 300, particularly the filter (not shown), may filter out PFAS and other micropollutants that may be retained in the unfiltered milk or other liquid. In embodiments, the second collection bottle 316 may also be fluidly coupled to the filtration device 300 to receive the now filtered or becoming filtered breast milk, in real time, from the first collection bottle 302. In embodiments, not only are the PFAS and other micropollutants removed, the filtration device 300 may filter the breast milk without changing (or minimally changing) the nutritional profile of the breast milk. In embodiments, the filtration device 300 can reduce PFAS concentration in breast milk by up to 85%. In embodiments, the filtration device 300 can reduce PFAS concentration in breast milk by up to 90%. In embodiments, the filtration device 300 can reduce PFAS concentration in breast milk by greater than or equal to 90%. In embodiments, the filtration device 300 can reduce PFAS concentration in breast milk by greater than 99%. In embodiments, the reduction or removal of PFAS concentration may be performed while minimally altering the milks nutritional profile by 5% or less. In some embodiments, the filtration device 300 can include a valve 332 configured to enable gas that may be trapped within the collection bottle 312 to escape as breast milk flows into the second collection bottle 312 and displaces the gas.
[0040] With additional reference to
Example Study Analysis
[0041] Rigor of Prior Research
[0042] Previous studies on PFAS contamination in breast milk was important, foundational work linking breastfeeding to infant exposure to PFAS. However, these studies offer limited recommendations for intervention and lag behind the current regulatory reality. Several studies have linked increased PFAS concentrations in the serum of reproductive age and pregnant women to dietary factors like consumption of seafood or tap (versus bottled) water. This work has led to recommendations for lifestyle changes to limit further PFAS exposure like filtering drinking water, checking local fish advisories before consuming locally sourced fish or seafood, and avoiding household products known to contain PFAS. However, these recommendations only address future, additional exposure to PFAS in the body of a breastfeeding mother and do not address prior accumulation. These studies also lag behind the current regulatory climate as they do not include newer PFAS compounds without manufacturing restrictions, like GenX. Our study investigated the efficacy of an intervention strategy to address prior accumulation in the body of a breastfeeding mother and includes the newer, less restricted GenX.
[0043] Innovation
[0044] Despite the well-documented contamination of breast milk with PFAS, there has been no current tests or products for mothers to address this issue. Trusted authorities, like the CDC, acknowledge that PFAS contamination in breast milk is a problem but state that the benefits of breastfeeding outweigh the problems associated with PFAS exposure. Even state-of-the-art breast milk testing, like that provided by the Lactation Lab, does not address PFAS contamination in breast milk. Unlike many nutritional deficiencies, there is nothing a nursing mother can do to lower the PFAS concentration resulting from accumulation throughout her life. Current filtration technologies for removing PFAS from water, such as carbon, ion exchange, reverse osmosis, and cyclodextrin, have never been applied to breast milk. These technologies have been proven effective in drinking water matrices and are recommended to nursing mothers to mitigate additional PFAS exposure. In embodiments, the filtration device as illustrated herein aids in PFAS removal from breast milk and addresses PFAS already accumulated in the bodies of nursing mothers.
[0045] The filter embodiments, as described herein, may be composed of cyclodextrin, a non-toxic, naturally occurring sugar that has been shown to remove 99% of PFOS from water. The use of technology with a non-toxic, natural media prevents the introduction of leachates that may be toxic or synthetic. Utilizing cyclodextrin as the filtration media, versus the drinking water industry's common technologies of carbon, ion exchange, and reverse osmosis, also allows an increased specificity for PFAS compounds. The addition of amine groups to the cyclodextrin molecule greatly increases the specificity and binding affinity for PFAS, including short- and long-chain compounds. Whereas other technologies rely on size and charge filtration, which would likely impact many other nutrients and microbial components of the complex matrix of breast milk, cyclodextrin's unique molecular structure and specificity for PFAS minimizes the incidental filtration of beneficial components of the breast milk matrix. This functionality makes cyclodextrin an ideal media, as it will remove PFAS without interfering with the major nutritional benefits of breast milk. Analysis can be found in Table 1 below.
TABLE-US-00001 TABLE 1 Competitive Landscape for PFAS Filters for Breast milk and Formula Review of available technologies utilized in drinking water PFAS remediation. EPA health advisory (HA) level of 70 ppt for PFOA, PFOS. Breast Cost Product Removal Removal Filtration Milk Targets PFAS per (Manufacturer) Mechanism Efficiency location Compatible Accumulation use Kaehler Science for Cyclodextrin 85% (Phase I) Breast pump Yes Yes $ Women 99.7% (Phase II) or bottle eSpring Water Carbon and EPA HA level Point of use No No $ $ Treatment (Amway) UV light [70 ppt] The Clean Water Carbon, ion EPA HA level Point of use No No $ Filter (A. O. Smith) exchange [70 ppt] PFA694E (Purolite) Ion EPA HA level Point of use No No $ $ $ exchange [70 ppt] resin E-series (Suez) Reverse EPA HA level Point No No $ $ osmosis [70 ppt] of entry
[0046] Preliminary Data:
[0047] Analyses for both the measure PFAS removal efficiency with the filtration device, and the monitoring of the nutritional profile of breast milk before and after filter use, from one breast milk donor is provided in Tables 2 and 3 below. PFAS quantification analyses were run in triplicate pre- and post-filtration (Table 2). PFOS and GenX were below the limit of detection in this breast milk sample. The PFAS removal efficiency of cyclodextrin has also been measured in water at comparable concentrations (Table 2). Breast milk nutritional analyses were conducted on a single sample pre- and post-filtration (Table 3).
TABLE-US-00002 TABLE 2 Preliminary Results - Effective PFAS Removal Pre-filtration Post-filtration Analyte Concentration Concentration Breast milk PFOA 4352 ppt Non-Detectable Water.sup.36 PFOA 10.sup.6 ppt >90% PFOS 10.sup.6 ppt >90% GenX 10.sup.6 ppt >90%
TABLE-US-00003 TABLE 3 Preliminary Results - Nutritional Content of Breast milk Pre- and Post-filtration Pre-filtration Post-filtration Analyte Concentration Removal Calories 62 kcal/dl 60 kcal/dl Carbohydrates 8.9 g/dl 8.7 g/dl Fat 2.3 g/dl 2.1 g/dl Protein 1.1 g/dl 0.9 g/dl
[0048] The filtration device may be able to reduce PFAS concentration in breast milk to protective levels, as preliminary data shows that the filter media reduces PFAS concentrations in breast milk to below the limit of detection and may remove more than 90% of PFAS compounds in water at concentrations comparable to that found in breast milk.
[0049] Furthermore, the filter will not negatively (or minimally) impact the nutritional quality of breast milk, as the preliminary data indicates that changes in calories, carbohydrate, fats, and proteins pre- and post-filtration are not significant, as Table 3 demonstrates.
[0050] Various embodiments of systems, devices, and methods have been described herein. These embodiments are given only by way of example and are not intended to limit the scope of the claimed inventions. It should be appreciated, moreover, that the various features of the embodiments that have been described may be combined in various ways to produce numerous additional embodiments. Moreover, while various materials, dimensions, shapes, configurations and locations, etc. have been described for use with disclosed embodiments, others besides those disclosed may be utilized without exceeding the scope of the claimed inventions.
[0051] Persons of ordinary skill in the relevant arts will recognize that the subject matter hereof may comprise fewer features than illustrated in any individual embodiment described above. The embodiments described herein are not meant to be an exhaustive presentation of the ways in which the various features of the subject matter hereof may be combined. Accordingly, the embodiments are not mutually exclusive combinations of features; rather, the various embodiments can comprise a combination of different individual features selected from different individual embodiments, as understood by persons of ordinary skill in the art. Moreover, elements described with respect to one embodiment can be implemented in other embodiments even when not described in such embodiments unless otherwise noted.
[0052] Although a dependent claim may refer in the claims to a specific combination with one or more other claims, other embodiments can also include a combination of the dependent claim with the subject matter of each other dependent claim or a combination of one or more features with other dependent or independent claims. Such combinations are proposed herein unless it is stated that a specific combination is not intended.
[0053] Any incorporation by reference of documents above is limited such that no subject matter is incorporated that is contrary to the explicit disclosure herein. Any incorporation by reference of documents above is further limited such that no claims included in the documents are incorporated by reference herein. Any incorporation by reference of documents above is yet further limited such that any definitions provided in the documents are not incorporated by reference herein unless expressly included herein.
[0054] For purposes of interpreting the claims, it is expressly intended that the provisions of 35 U.S.C. § 112(f) are not to be invoked unless the specific terms “means for” or “step for” are recited in a claim.